T. Rechlin et al., HEART-RATE-VARIABILITY IN DEPRESSED-PATIENTS AND DIFFERENTIAL-EFFECTSOF PAROXETINE AND AMITRIPTYLINE ON CARDIOVASCULAR AUTONOMIC FUNCTIONS, Pharmacopsychiatry, 27(3), 1994, pp. 124-128
Twenty-four unmedicated patients with episodes of major depression (DS
M-III-R) and an age- and sex-matched group of 24 normal subjects under
went a heart rate analysis. The battery of cardiovascular reflex tests
included the coefficient of variation while resting (CVr) and during
deep breathing (CVdr), a spectral analysis of heart rate variability,
the Valsalva test, and the posture index. The depressed patients showe
d no significant abnormities in any of the tests as compared to the he
althy subjects. The 24 patients were randomly allocated for treatment
with either amitriptyline or paroxetine. During treatment with 20 mg p
aroxetine per day, patients showed no changes in cardiovascular autono
mic function tests after 14 days. However, treatment with 150 mg amitr
iptyline per day decreased all heart rate parameters significantly due
to anticholinergic side effects, except heart rate, which increased s
ignificantly. As autonomic side effects are a potential hazard of anti
depressant therapy, the data suggest that paroxetine is an appropriate
antidepressant for cases with pre-existing cardiovascular autonomic n
europathy.